Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.
Brian Nagle, MD
Advertisement
Resident physician, MedStar Georgetown University Hospital, in Washington, DC
Articles by Brian Nagle, MD
Advertisement
Latest Updated Articles
Promising Disease-Modifying Therapies in Parkinson DiseasePublished: April 19th 2023 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Accepts New Drug Application for Tau PET Imaging Agent MK-6240 in Alzheimer Disease
2
Understanding VTX3232’s Effects on Patients with Early-Stage Parkinson Disease
3
Exenatide Alters Motor Network Activity in Parkinson Disease, Though Clinical Impact Remains Limited
4
Key Diagnostic Pearls for NMOSD Recognition and Testing: Elena Grebenciucova, MD
5
